My Cart [ 0 ]
Home > Antibodies > A-Z Primary Antibodies > TNFRSF4 Antibody

TNFRSF4 Antibody

CD134; TXGP1L; ACT35; OX40; OX40L receptor; OX40 antigen; ACT35 antigen; Lymphoid activation antigen ACT35

Catalog No. Product Name Size List Price (US$) Quantity
PA006777-PA2136-3 TNFRSF4 Polyclonal Antibody 100 ug 350.00
Description

Introduction
Tumor necrosis factor receptor superfamily, member4, also known as ACT35 or CD134 is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. CD134 was mapped to 1p36 by fluorescence in situ hybridization. CD134 is the primary receptor for feline immunodeficiency virus. CD134 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development.
 

PA006777-PA2136-3: TNFRSF4 Polyclonal Antibody

Rabbit Polyclonal Antibody.
Applications: WB 0.1-0.5 ug/ml.
Reactivity: Rat.
Immunogen: A synthetic peptide corresponding to a sequence at the N-terminal of rat TNFRSF4.
Purification: Immunogen affinity purified.
Form of Antibody: Each vial contains 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.
Isotype: Rabbit IgG.

Storage/Stability: Stable for 1 year at -20°C and 3 months at 4°C. For maximum recovery of the product, centrifuge the original vial after thawing and before removing the cap. Aliquot to avoid repeated freezing and thawing.

Related Links

See our Privacy Policy